Journal
NATURE MEDICINE
Volume 18, Issue 6, Pages 854-856Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2799
Keywords
-
Ask authors/readers for more resources
Metastatic colorectal cancer is a largely incurable disease with a pressing need for targeted therapies. A new study sheds light on a surprising interaction between FOXO3a and beta-catenin in metastatic colorectal cancer, suggesting new therapeutic avenues for agents targeting the PI3K-AKT pathway (pages 892-901).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
